Skip to content

6-KAccepted Mar 5, 4:05 PM ET

Agomab Therapeutics NV 6-K

AGMBAgomAb Therapeutics NV

sec.gov(opens the filing on sec.gov)View full filing

Accepted (ET)

4:05 PM

Mar 5, 2026

Filed

Mar 5, 2026

Documents

2

Size

130.5 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.